Literature DB >> 24347027

Cell proliferation arrest and redox state status as part of different stages during senescence establishment in mouse fibroblasts.

Francisco Triana-Martínez1, Norma E López-Diazguerrero, Luis A Maciel-Barón, Sandra L Morales-Rosales, Sonia Galván-Arzate, Francisco J Fernandez-Perrino, Alejandro Zentella, Viviana I Pérez, Luis E Gomez-Quiroz, Mina Königsberg.   

Abstract

Senescence phenotype can be achieved by multiple pathways. Most of them involve the activation of negative cell cycle regulators as well as a shift to an oxidative status. However, the exact participation of these events in senescence establishment and maintenance is not completely understood. In this study we investigated the content of three final cell cycle regulators, as well as the redox state in some critical points during the pre-senescent and the full-senescent states. Our results highlight the existence of a critical pre-phase in senescent phenotype establishment, in which cell proliferation stops with the participation of the cell cycle inhibitors, and a second maintenance stage where the exacerbated pro-oxidant state inside the cell induces the physiological decline characteristic in senescent cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24347027     DOI: 10.1007/s10522-013-9488-6

Source DB:  PubMed          Journal:  Biogerontology        ISSN: 1389-5729            Impact factor:   4.277


  2 in total

1.  Senescence associated secretory phenotype profile from primary lung mice fibroblasts depends on the senescence induction stimuli.

Authors:  L A Maciel-Barón; S L Morales-Rosales; A A Aquino-Cruz; F Triana-Martínez; S Galván-Arzate; A Luna-López; V Y González-Puertos; N E López-Díazguerrero; C Torres; Mina Königsberg
Journal:  Age (Dordr)       Date:  2016-02-11

Review 2.  Senescence: Pathogenic Driver in Chronic Obstructive Pulmonary Disease.

Authors:  Melissa Rivas; Gayatri Gupta; Louis Costanzo; Huma Ahmed; Anne E Wyman; Patrick Geraghty
Journal:  Medicina (Kaunas)       Date:  2022-06-17       Impact factor: 2.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.